ITGB3 and Glanzmann thrombasthenia 1: Consequences of variants in ITGA2B and ITGB3 in GT patients were reported to cause lack of function, prevention of αIIbβ3 expression, and are associated with activated integrin defects and macrothrombocytopenia.